RMEI Continuing Medical Education Neuroscience

Neuroscience CE Activities

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CE Credit(s)

Spinal Muscular Atrophy: An Interprofessional Approach

0.75 CE Credit(s)

Realizing the Promise of Interprofessional Care and Collaboration in Multiple Sclerosis

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

CE Credit Expired

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience
Decision Support Aid

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience, Psychiatry
Decision Support Aid

LATEST NEUROSCIENCE ARTICLES

Latest Neuroscience Articles

Upadacitinib — An Up-and-Comer for Treatment of Giant-Cell Arteritis May 29, 2025
Ever since the early use of cortisone for giant-cell arteritis in the 1950s,1 glucocorticoids have been a foundational treatment for this form of large-vessel vasculitis, providing clinical benefit and reducing the risk of blindness. Indeed, for almost seven decades, the treatment of giant-cell arteritis had been limited largely...
Matthew J. Koster, Kenneth J. Warrington
Novel Proteins to Neutralize Venom Toxins May 29, 2025
This article describes how machine-learning tools were used to design novel protein inhibitors that proved effective against snake-venom toxins in mice.
José María Gutiérrez
The Meaning of Goodbye May 29, 2025
When a physician’s wife has Alzheimer’s disease — the worst disease for the patient’s partner, according to their doctor — he must grapple with effects more challenging than memory loss.
David Pisetsky

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021